Serum dosage of CPK-MB in dogs with ST deviation by chemiluminescence

• Main Authors: André L.F. Santos, Guilherme G. Pereira, Mário M. Santos, Vanda C.R. Gutierrez, Priscila C. Calyjur, Maria Helena M.A. Larsson
• Format: Article
• Language: English
• Published: Colégio Brasileiro de Patologia Animal (CBPA) 2014-12-01
• Series: Pesquisa Veterinária Brasileira
• Subjects: Creatinafosfoquinase; CPK-MB; cães; segmento ST
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2014001300074&lng=en&tlng=en

Abstract: Although frequently in humans, hypoxic and ischemic heart diseases are poorly documented in dogs, with only few reports of acute myocardial infarction (AMI) in this species. Some electrocardiographic findings might suggest myocardium hypoxia/ischemia, like ST segment elevation or depression, but there are no studies showing whether deviations in ST segment are associated to myocardial injury and serum increase of creatine phosphokinase (CPK-MB). In order to investigate possible myocardial cells injury in poor perfusion conditions, 38 dogs were studied, 20 with normal electrocardiogram and 18 with ST segment elevation or depression, recorded in lead II, at a paper speed of 50 mm/sec and N sensibility (1mV=1cm). Serum measurement of creatine phosphokinase isoenzyme MB (CPK-MB) in normal dogs (group 1) determined control values (in ng/mL), which were compared to those obtained from dogs with deviation (group 2), which allowed confirmation or not of myocardial injury. CPK-MB mean values obtained from dogs in groups 1 and 2 were 0.540ng/ml (SD±0.890)ng/mL and 0.440ng/mL (SD±1.106), respectively. At a significance level of 5%, the relation of CPK-MB with age, mass and total creatine phosphokinase (CPK-T) was not significant in groups 1 and 2. CPK-MB showed no difference, at 5% level, between groups 1 and 2. In conclusion, it is possible to use the human chemiluminescent immunometric assay kit in canine species and that hypoxia/ischemia revealed by ST segment deviation does not mean significant myocardium injury.